Efficient differentiation kit generates high-purity myogenic cells
Cultured skeletal muscle myoblast (iMyoblast) used for isolation studies into Muscular Dystrophies. Credit: University of Massachusetts

Kits

Efficient differentiation kit generates high-purity myogenic cells

11 Feb, 2026

Amsbio has expanded its range of Skeletal Muscle Differentiation Kits, offering researchers a reliable solution for turning pluripotent or embryonic stem cells into myoblasts with strong regenerative potential. The kit’s streamlined 3-step protocol, involving simple media changes and cell passaging, routinely produces cultures with up to 70% MF20-positive myotubes - all without the need for genetic modification or laborious cell sorting, saving both time and effort.

Designed to work with any pluripotent stem cell line, the kits deliver a uniform, physiologically competent population of skeletal muscle cells that are immediately ready for drug screening, disease modelling, and other advanced applications. For added flexibility, Amsbio can supply kits directly from stock or provide bespoke services, generating skeletal muscle myoblasts from your iPSC line of choice to fit seamlessly into any workflow, whether speed or customisation is the priority.

More information online

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow